WCG’s endpoint management and training services are focused on easing the burden of study participation for investigators. We combine workflow automation powered by InvestigatorSpace® with process improvements developed in collaboration with subject matter experts to standardize endpoint scale management and training content.
Through partnerships with scientific and training organizations, we host training material for a range of indications in the Immunology/dermatology therapeutic area.
We also support assessment scale development and validation projects, for immune-dermatology indications. We have deep experience supporting these efforts and have developed specialized technology to support our customers.
In addition, we can manage the licensing of scale and training intellectual property (IP) either directly with the license owner or through their agency.
If you don’t see your preferred language on the list, we can usually localize standard training content in your language of choice in just weeks.
Rater scales we currently support:
|Atopic Dermatitis||vIGA-AD™ (Validated Investigator Global Assessment for Atopic Dermatitis)||English | Japanese | Simplified Chinese|
|Atopic Dermatitis||EASI/BSA for Atopic Dermatitis Training||English | Japanese | Simplified Chinese|
|Atopic Dermatitis||EASI/BSA Qualification Declaration Statement||English|
|Atopic Dermatitis||TLSS-AD Training (Target Lesion Severity Score for Atopic Dermatitis)||English | Japanese | Simplified Chinese|
|Atopic Dermatitis||SCORAD Training (SCORing for Atopic Dermatitis)||English | Japanese | Simplified Chinese|
|Psoriasis (General)||PASI/BSA (Psoriasis Area and Severity Index and Body Surface Area)||English | Japanese | Simplified Chinese|
|Psoriasis (General)||Five-Point sPGA (Static Physician’s Global Assessment)||English | Simplified Chinese|
|Psoriasis (General)||Five-Point Investigator/Physician Global Assessment 2011||English|
|Psoriasis (General)||Five-Point Investigator/Physician Global Assessment 2017||English|
|Psoriasis (General)||Six Point sPGA 2010||English|
|Psoriasis (General)||Six-Point sPGA – 2011||English|
|Psoriasis (General)||Six-Point sPGA 2012||English|
|Psoriasis (General)||TSS (Target Lesion Total Sign Score)||English | Simplified Chinese|
|Psoriasis (General)||Total Plaque Severity Score TPSS Training Module||English|
|Psoriasis (General)||Body Surface Area (BSA)||English|
|Psoriasis (Specialty)||PPPASI – (Palmar-Plantar Psoriasis Area & Severity Index)||English | Simplified Chinese|
|Psoriasis (Specialty)||PSSI (Psoriasis Scalp Severity Index)||English | Simplified Chinese|
|Psoriasis (Specialty)||sPGA-G™ Scale||English | Japanese | Simplified Chinese|
|Nail Psoriasis||NAPSI (Nail Psoriasis Severity Index)||English | Japanese | Simplified Chinese|
|Nail Psoriasis||Modified NAPSI||English|
|Nail Psoriasis||NAPSI Background||English|
|Psoriatic Arthritis||Joint Count Assessment||English|
|Psoriatic Arthritis||Assessment of Enthesitis and Dactylitis In PA-Leeds||English|
|Psoriatic Arthritis||Assessment of Enthesitis and Dactylitis in Psoriatic Arthritis||English|
|Psoriatic Arthritis||Assessment of Synovitis in Psoriatic Arthritis – Joint Count||English|
|Psoriatic Arthritis||Axial Spine Exam Training||English|
|Generalized Pustular Psoriasis||GPP-PGA (Generalized Pustular Psoriasis – Physician’s Global Assessment)||English|
|Generalized Pustular Psoriasis||JDA/CGI (modified Japanese Dermatological Association severity index/Clinical Global Impression Scale)||English|
|Palmoplantar Pustulosis||Palmoplantar Pustulosis (PPP) Disease Overview||English|
|Palmoplantar Pustulosis||PPPASI (Palmoplantar Pustular Psoriasis Area & Severity Index)||English|
|Palmoplantar Pustulosis||PP sIGA (Palmoplantar Pustulosis Static Investigator Global Assessment)||English|
|Palmoplantar Pustulosis||PPSI (Palmoplantar Pustulosis Severitity Index)||English|
|Myasthenia Gravis||Quantitative Myasthenia Gravis Training (QMG)||English | Japanese | Simplified Chinese | Traditional Chinese | Korean|
|Myasthenia Gravis||Myasthenia Gravis Composite Training (MG-ADL, QMG & MGC)||English|